VERTEX PHARMACEUTICALS INC / MA
VRTXPharmaceutical Preparations · SIC 2834 · CIK 0000875320
Revenue FY2025
$12.00B
Net Income
$3.95B
EPS (Basic)
$15.46
Net Margin
32.9%
ROE
21.2%
Total Equity
$18.67B
Shares Out
253M
VERTEX PHARMACEUTICALS INC / MA — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2008–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 12 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Capital World Investors
Capital World Investors
$12.97B
1.5%
+2.9%
Capital Research Global Investors
Capital Research Global Investors
$9.68B
1.4%
(7.7%)
Torray Funds
Torray
$0.01B
1.0%
(1.1%)
WCM Investment Management
WCM Investment Management
$0.58B
0.6%
+2.7%
Ashford Capital Management
Ashford Capital Management
$0.00B
0.5%
—
Motley Fool Asset Management
Motley Fool Asset Management
$0.01B
0.3%
(14.8%)
Tweedy Browne
Tweedy Browne
$0.02B
0.3%
(0.7%)
Adage Capital Management
Adage Capital Management
$0.20B
0.3%
+56.3%
Renaissance Technologies
Renaissance Technologies
$0.16B
0.2%
(24.1%)
Holocene Advisors
Holocene Advisors
$0.01B
0.0%
(81.7%)
Alps Advisors
Alps Advisors
$0.00B
0.0%
+116.8%
Bridgewater Associates
Bridgewater Associates
$0.01B
0.0%
(18.7%)
Insider Transactions
Reading stored insider transactions…